Font Size:
a
A
A
Keyword [tyrosine kinase inhibitor]
Result: 121 - 140 | Page: 7 of 10
121.
Bruton's Tyrosine Kinase Inhibitor PCI-32765 In The Treatment Of Aggressive B Cell Lymphoma And Its Action Mechanism
122.
Analysis Of Clinical Efficacy Of The Second Generation Tyrosine Kinase Inhibitor For CML-CP Patients Without Optimal Response To Imatinib
123.
Analysis Of The Emergence Of ABL Kinase Domain Mutations In Chronic Myelogenous Leukemia Treated With Tyrosine Kinase Inhibitor
124.
The Impact Of Tyrosine Kinase Inhibitor On The T Lymphocyte
125.
Treatment And Prognosis Analysis Of 60 Cases Of Different EGFR Mutations Status In Non-small Cell Lung Cancer With Brain Metastasis
126.
The Correlation Study Of EGFR Mutation With Expression Of EGFR,TTF-1 And Serum CEA Level In Lung Adenocarcinoma
127.
Clinical Analysis Of 19 BCR-ABL Positive Childhood Acute Lymphoblastic Leukemia
128.
Relationship Between CYP3A4 Gene Polymorphism And Treatment Efficacy For Advanced Non-small Cell Lung Cancer With Tyrosine Kinase Inhibitor
129.
Icotinib Alone Or With Radio Therapy In Patients With EGFR Mutations Non-small Cell Lung Cancer Who Develop Brain Metastases
130.
Synthesis And Activity Evaluation Of Novel Tyrosine Kinase Inhibitors And Synthesis Of New Anti-Radiation Molecules
131.
Analysis Of Prognostic Factors In Ph Chromosome Positive Acute Lymphoblastic Leukemia
132.
Investigation Of EGFR Gene Mutation In Lung Squamous Cell Carcinoma And The Effect Of EGFR-TKI Treatment On Advanced EGFR Mutation
133.
The Clinical Observation Of EGFR-TKI Rechallenge With Antiangiogenic Agents In Advanced NSCLC
134.
Role Of Tyrosine Kinase Inhibitor (Genistein) In Retinal Neovascularization In Mice
135.
The Differences Of Efficacy Of Chemotherapy And Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor In Advanced Lung Adenocarcinoma Patients Harboring 19del And L858R Mutation
136.
Effect Of A Novel Tyrosine Kinase Inhibitor On The Growth Of Hepatocellular Carcinoma Cells
137.
Synergistic Inhibition Of Tumor By Co-delivery Of Dasatinib And All-trans Retinoic Acid Via Self-assembled Nanoparticles
138.
Efficacy And Mechanism Study Of Multi-tyrosine Kinase Inhibitor AL3810 Against Thyroid Cancer
139.
The Expression And Function Of PD-1/TIM3 And Their Ligands In FLT3-ITD Positive Acute Myeloid Leukemia
140.
Comparison Of The Clinical Outcome Of Gefitinib For Advanced Lung Adenocarcinoma With Positive Epidermal Growth Factor Receptor Mutated In Exon 21 Or 19 Del Between Patients Treated With First And Second Line Therapy
<<First
<Prev
Next>
Last>>
Jump to
